Melissa Hadley Barrett discusses real-world outcomes and tolerability of intranasal vardenafil for men with persistent erectile dysfunction despite prior standard therapy. Timothy N. Clinton, MD, ...
Melissa Hadley Barrett discusses real-world outcomes and tolerability of intranasal vardenafil for men with persistent erectile dysfunction despite prior standard therapy.
These FAQs outline key recommendations and practical takeaways from the AUA/SUO guideline amendment on the diagnosis and treatment of NMIBC. The management of non–muscle invasive bladder cancer (NMIBC ...
Daniel Spratt, MD, reviews how closely MMAI-predicted 10-year distant metastasis and prostate cancer–specific mortality tracked observed STAR-CAP outcomes, including among patients treated with ...
The minimally invasive surgical therapy is approved for the treatment of lower urinary tract symptoms secondary to BPH. The FDA has approved the Optilume BPH Catheter System for the treatment of lower ...
In the phase 3 PACE-A trial, SBRT and prostatectomy showed similar 8-year disease control in localized prostate cancer, with lower rates of urinary incontinence after SBRT. Using PSMA-PET imaging and ...
Pastuszak discusses the evolving nature of understanding how testosterone therapy post-radiation for prostate cancer may beneficial or harmful to patients, and how to navigate the decision. Overall, a ...
Dr. Michael Lipkin discusses a recent study conducted at Duke University Hospital that found that a new single-use cystoscope demonstrated superior flexion and comparable optics to the reusable scopes ...
Farah Rahman, MD, MPH, highlights a pilot study on the use of wearable biofeedback technology to better understand and address burnout among urology residents. Sudha Jayaraman, MD, MSc, FACS, recaps a ...
Although low, men experienced a higher risk for erectile dysfunction and hypogonadism after being prescribed semaglutide for weight loss; however, further questions remain. Non-diabetic men treated ...
Fast track designation for 64Cu-SAR-bisPSMA enables accelerated development and review for prostate cancer imaging. Phase 1/2 COBRA trial showed 64Cu-SAR-bisPSMA's efficacy in detecting lesions missed ...
Experts discuss why accurately recognizing CIS in patients with suspected NMIBC is essential to preventing disease progression, guiding surveillance, and expanding treatment and clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results